StemBioSys
is a Texas-based biomedical company that researches and develops stem cell-derived cardiomyocyte substrates for predicting cardiac safety from drugs... Read moreStemBioSys
is a Texas-based biomedical company that researches and develops stem cell-derived cardiomyocyte substrates for predicting cardiac safety from drugs... Read more
News
Dec 04, 2023
The Business Journals
StemBioSys: StemBioSys secures new chair as it clears Covid hangover
Jul 17, 2023
The Business Journals
StemBioSys: StemBioSys' launches new product that could slow animal testing
Jun 13, 2023
Yahoo
StemBioSys: StemBioSys Announces Launch of CELLvo Atrial Cardiomyocyte, a Technological Leap Forward in Cardiotoxicity Screening
May 15, 2023
StemBioSys Blog
StemBioSys Blog StemBioSys Awarded an SBIR Grant to Advance Islet Transportation using ECM
May 01, 2023
StemBioSys Blog
StemBioSys Blog HepatoMatrix: Maturing Hepatocytes For in Vitro Hepatotoxicity Testing
Apr 05, 2023
StemBioSys Blog
StemBioSys Blog CCN1 and the Bone Marrow Mesenchymal Stem Cell Niche
Apr 04, 2023
StemBioSys Blog
StemBioSys Blog Scientist Spotlight: Anne Sheldrake
Mar 02, 2023
StemBioSys Blog
StemBioSys Blog NeuroMatrix and Challenges in Neuronal Culture
Feb 14, 2023
The Business Journals
StemBioSys: StemBioSys CEO: Company poised for huge gains from new launch
Feb 13, 2023
Benzinga
StemBioSys: StemBioSys Announces Launch of NeuroMatrix , a Technological Leap Forward in Laboratory Production of Functionally Mature Human Neural Cell Types
StemBioSys Competitors
1
2
3
4
5
6
7
8
9
10